Why is Rossari Biotech falling/rising?

As of 18-Aug, Rossari Biotech Ltd's stock price is currently at 638.30, reflecting an increase of 13.8 or 2.21%. The stock has shown a trend reversal, gaining after seven consecutive days of decline, and it outperformed its sector by 1.19% today. However, despite this positive movement, the stock is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a longer-term downtrend. Over the past year, the stock has generated a return of -30.16%, and its profits have decreased by 1%. The company maintains a low debt-to-equity ratio of 0.03, and with a return on equity of 11.5, it is considered to have an attractive valuation compared to its peers, trading at a discount to average historical valuations.
In the broader market context, the stock's short-term performance of +0.39% over the past week is underwhelming compared to the Sensex, which has increased by 0.83% in the same period. Additionally, the stock has consistently underperformed against the benchmark over the last three years, with a significant decline of -32.76% compared to the Sensex's +34.79% during that time. The high institutional holdings at 21.32% suggest that these investors have the resources to analyze the company's fundamentals, which may influence market sentiment. However, the flat results reported on June 25 and the lowest return on capital employed at 14.46% further contribute to the stock's challenges in gaining traction in the market.